Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00588614 · ClinicalTrials.gov registry record
High Risk Screening Breast MR Using a Rapid Imaging Exam
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 140
- Enrollment target
NCT00588614: Completed study, sponsored by Mayo Clinic.
NCT00588614 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 140 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00588614 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 140 participants
- Enrollment target
Study Summary
This study is being done to find out if breast cancer detection will be improved using a short MRI (magnetic resonance imaging) scan, in addition to mammography, in patients who are at an increased risk of developing breast cancer.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 140 participants |
| Start Date | 2006-04 |
| Est. Completion | 2011-02 |
What the finished NCT00588614 record still lists
NCT00588614 is an observational study that tracks outcomes without assigning an intervention. The registered 140 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00588614 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00588614 about?
NCT00588614 is a clinical study titled "High Risk Screening Breast MR Using a Rapid Imaging Exam". This study is being done to find out if breast cancer detection will be improved using a short MRI (magnetic resonance imaging) scan, in addition to mammography, in patients who are at an increased risk of developing breast cancer.
What is the current status of trial NCT00588614?
This trial is currently completed. The enrollment target is 140 participants. The study started on 2006-04. Estimated completion is 2011-02.
Who is sponsoring clinical trial NCT00588614?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01419561 · 140 participants · Phase 2
Natural History Study of the KSHV Inflammatory Cytokine Syndrome (KICS)
- NCT01624805 · 140 participants · Phase 2
Methylprednisolone, Horse Anti-Thymocyte Globulin, Cyclosporine, Filgrastim, and/or Pegfilgrastim or Pegfilgrastim Biosimilar in Treating Patients With Aplastic Anemia or Low or Intermediate-Risk Myelodysplastic Syndrome
- NCT02369770 · 140 participants · NA
Sensory-Motor Rehabilitation Post Stroke
- NCT02455193 · 140 participants · NA
Neuronal Effects of Exercise in Schizophrenia
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia